Skip to main content

Scholarly Activities

Duke Radiation Oncology encourages resident scholarly pursuits in areas of their choosing. Traditional Track Residents spend PGY-4 assigned to Scholarly Activity. Radiation Oncology Research Scholar Residents will spend 21 months assigned to Scholarly Activity. During their dedicated Scholarly Activity time, Residents have the freedom to pursue well defined mentored projects that they are passionate about. Residents have used the Scholarly Activity time to write prospective clinical trials, engage in basic science laboratory based work and perform health services research. Additionally, during their Scholarly Activity time, residents have pursued Masters degrees in Clinical Research and Global Health, as well as Fellowships in Healthcare Administration.

The plan for activities during Resident Scholarly Activity time are developed in the year prior as discussions between the resident, the Residency Program Director, the Department Chair, the Director of Clinical Research, the Vice Chair for Translational and Basis Research and the Radiation Oncology Research Team. These discussions ensure that each resident has appropriate mentorship as well as the necessary resources to maximize their time and available opportunities. 

Duke Radiation Oncology Residents present their scholarly work at national and international meetings, funded by the Department. Our residents routinely have oral podium presentations at the ASTRO annual meeting, and often their work has been designated "Best of ASTRO." Additionally, accepted oral presentations, with the Program Director's prior approval, have been presented by our residents at the European Society for Radiotherapy and Oncology (ESTRO) annual meeting, as well as the ASCO annual meeting, Society for Radiation Research meetings, Society for Neuro-Oncology meetings and others.
 

Resident Publications

2020
  • ​​Jacobs C, Gao J, Wang W, Ready NE, Clarke JM, Tong B, Suneja G, Kelsey CR, Torok JA. Definitive Radiotherapy for Inoperable Stage IIB Non-Small Cell Lung Cancer: Patterns of Care and Comparative Effectiveness. Clin Lung Cancer. 2020 May; 21(3):238-246.
  • Jacobs C, Trotter J, Palta M, Yuan W, Willett CG, Lee WR, Czito BG. Multi-Institutional Analysis of Synchronous Prostate and Anorectosigmoid Cancers. Frontiers in Oncology. 2020 Mar; 10:345.

  • Barbour AB*, Jacobs C*, Williamson H, Floyd SR, Suneja G, Torok JA, Kirkpatrick JP. Radiotherapy Practice Patterns for Brain Metastases in the United States in the Stereotactic Radiosurgery Era. Adv Radiat Oncol. 2020 Jan. 5(1):43-52. *Co-first author.

  • Chodavadia P*, Jacobs C*, Wang F, Havrilesky LJ, Chino JP, Suneja G. Off-Study Utilization of Experimental Therapies: Analysis of GOG249-Eligible Cohorts Using Real World Data. Gynecologic Oncology. 2020 Jan; 156(1):154-161. *Co-first author.

  • Proctor L, Hoang L, Moore J, Thompson E, Leung S, Natesan D, Chino J, Gilks B, McAlpine JN. Association of human papilloma virus status and response to radiotherapy in vulvar squamous cell carcinoma. Int J Gynecol Cancer. 2020 Jan; 30(1):100-106. doi: 10.1136/ijgc-2019-000793. Epub 2019 Nov 25. PMID: 31771962.

  • Chiang J, Diaz AK, Makepeace L, Li X, Han Y, Li Y, Klimo P, Boop FA, Baker SJ, Gajjar A, Merchant TE, Ellison DW, Broniscer A, Patay Z, Tinkle CL. Clinical, imaging, and molecular analysis of pediatric pontine tumors lacking characteristic imaging features of DIPG. Acta neuropathologica communications 2020 ;8(1):57. DOI:10.1186/s40478-020-00930-9.

2019
  • Carpenter DJ, Jacobs C, Wong T, Craciunescu O, Chino JP. Changes on Mid-Chemoradiotherapy FDG-PET/CT for Cervical Cancer are Associated with Prognosis. Int J Radiation Oncol Biol Phys. 2019 Oct; 105(2):356-366.
  • Corradetti MN, Torok JA, Hatch AJ, Xanthopoulos EP, Lafata K, Jacobs C, Rushing C, Calaway J, Jones G, Kelsey CR, Nixon AB. Dynamic Changes in Circulating Tumor DNA During Chemoradiation for Locally Advanced Lung Cancer. Adv Radiat Oncol. 2019 Oct; 4(4):748-52.
  • Jacobs C, Palta M, Willett CG, Czito BG. Perioperative Systemic Therapy Versus Neoadjuvant Chemoradiotherapy for Operable Gastroesophageal Junction Cancers. Gastrointestinal Cancers Symposium ASCO Daily News. 2019 Oct. https://dailynews.ascopubs.org/do/10.1200/ADN.19.190446/full/?cid= DM4325&bid=35132818

  • Wang H, Diaz AK, Shaw TI, Li Y, Niu M, Cho JH, Paugh BS, Zhang Y, Sifford J, Bai B, Wu Z, Tan H, Zhou S, Hover LD, Tillman HS, Shirinifard A, Thiagarajan S, Sablauer A, Pagala V, High AA, Wang X, Li C, Baker SJ, Peng J. Deep multiomics profiling of brain tumors identifies signaling networks downstream of cancer driver genes. Nature Communications. 2019 Aug 16;10(1):3718. DOI:10.1038/s41467-019-11661-4.
  • Jacobs C, Palta M, Williamson H, Price JG, Czito BC, Salama JK, Moravan MJ. Hypofractionated Image-Guided Radiation Therapy with Simultaneous-Integrated Boost Technique for Limited Metastases: A Multi-Institutional Analysis. Frontiers in Oncology. 2019 Jun; 9:469.
  • Natarajan B, Jacobs C, Salama JK. Radiotherapy and Small Cell Carcinoma with Paraneoplastic Polyneuropathy. Annals of Internal Medicine. 2019 Jun; doi: 10.7326/L19-0236.
  • Jacobs C, Carpenter DC, Hong JC, Havrilesky LJ, Sosa JA, Chino JP. Radiation Records in the National Cancer Database: Variations in Coding and/or Practice Can Significantly Alter Survival Results. JCO Clin Cancer Inform. 2019 May:3:1-9. doi: 10.1200/CCI.18.00118. PMID: 31050906.
  • Chino F. Resident Voice: “Failure is the mother of success” and other advice on resident research. Applied Radiation Oncology. 2019 Mar 18;8(1):5-6.
  • Spiegel DY, Hong JC, Oyekunle T, Waters L, Lee WR, Salama JK, Koontz BF. A nomogram for testosterone recovery following combined androgen deprivation and radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2019 Mar 15;103(4):834-842. doi: 10.1016/j.ijrobp.2018.11.007. PMID: 30419308.
  • Spiegel DY, Boyer MJ, Hong JC, Williams CD, Kelley M, Salama JK, Palta M. Long-term Clinical Outcomes of Nonoperative Management with Chemoradiotherapy for Locally Advanced Rectal Cancer in the Veterans Health Administration. Int J Radiat Oncol Biol Phys. 2019 Mar 1;103(3):565-573.doi: 10.1016/j.ijrobp.2018.10.018. PMID: 30359718.
  • Jacobs C, Horton J, Blitzblau R, Suneja GS. Synchronous Breast Cancer and Primary Mediastinal B-cell Lymphoma. Practical Radiation Oncology. 2019 Mar; 9(2): featured on the cover.
  • Chino F, Kamal A, Chino J, LeBlanc T. Disparities in Place of Death for Patients with Hematological Malignancies, 1999-2015. Blood Advances. 2019 Feb 12;3(3):333-338. doi: 10.1182/bloodadvances. 2018023051.
  • Hong JC, Boyer MJ, Spiegel DY, Williams CD, Tong BC, Shofer SL, Moravan MJ, Kelley MJ, Salama JK. Increasing PET Use in Small Cell Lung Cancer: Survival Improvement and Stage Migration in the VA Central Cancer Registry. J Natl Compr Canc Netw. 2019 Feb;17(2):127-139 doi: 10.6004/jnccn.2018.7090. PMID:30787126.
  • Jacobs C, Barbour AB, Mowery YM. The Relative Distribution of Oral Cancer in the United States by Subsite. Oral Oncol. 2019 Feb; 89:56-68.
  • Lafata KJ, Hong JC, Geng R, Ackerson BG, Liu JG, Zhou Z, Torok J, Kelsey CR, Yin FF. Association of Pre-treatment Radiomic Features with Lung Cancer Recurrence Following Stereotactic Body Radiation Therapy. Phys Med Biol. 2019 Jan 8:64(2):025007. doi: 10.1088/1361-6560/aaf5a5. PMID: 30524018.
  • Chino F, Zafar SY. 2019 ASCO Educational Book: Financial Toxicity and Equitable Access to Clinical Trials. Am Soc Clin Oncol Educ Book. 2019 Jan;39:11-18. doi: 10.1200/EDBK_100019. Epub 2019 May 17.
  • Jacobs C, Chino JP, Suneja GS. Locally Advanced Cervical Cancer Invading the Rectum and Bladder. Practical Radiation Oncology. 2019 Jan; 9(1): featured on the cover.
  • Jacobs C, Moravan MJ, Choe J, Kahmke R, Mowery Y, Salama JK. Cancers of the Oral Cavity: Diagnosis and Treatment. Encyclopedia of Cancer, 3rd Edition. Elsevier. 2019: 131-168.
2018
  • Hong JC, Niedzwiecki D, Palta M, Tenenbaum JD. Prediciting Emergency Visits and Hospital Admissions During Radiation and Chemoradiation: An Internally Validated Pretreatment Machine Learning Algorithm. JCO Clin Cancer Inform. 2018 Dec 2:1-11. doi:10.1200/CCI.18.00037. PMID: 30652595
  • Hong JC, Cui Y, Patel BN, Rushing CN, Faught A, Eng J, Higgins K, Yin FF, Das S, Czito BG, Willett CG, Palta M. Association of interim FDG-PET imaging during chemoradiation for quamous anal canal carcinoma with recurrence. Int J Radiat Oncol Biol Phys. 2018 Nov 15: 102(4): 1046-1051; https://doi.org/10.1016/j.ijrobp.2018.04.062. PMID: 29891206.
  • Tandberg DJ, Cui Y, Rushing CN, Hong JC, Ackerson B, Marin D, Zhang X, Czito BG, Willett CG, Palta M. Intra-treatment response assessment with 18F-FDG PET: Correlation of semi-quantitative PET features with pathologic response of esophageal cancer to neoadjuvant chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):1002-1007. doi: 10.1016/j.ijrobp.2018.07.187. PMID: 30055238.
  • Lafata K, Cai J, Wang C, Hong J, Kelsey C, Yin FF. Spatial-Temporal Variability of Radiomic Features and its Effect on the Classification of Lung Cancer Histology. Phys Med Biol. 2018 Nov 8;63(22):225003. doi: 10.1088/1361-6560/aae56a. PMID: 30272571.
  • Ackerson BG, Tong B, Hong JC, Gu L, Chino J, Lafata K, Torok J, Chang C, Kelsey CR. Stereotactic Body Radiation Therapy versus Sublobar Resection for Stage I NSCLC. Lung Cancer. 2018 Nov;125:185-191. doi: 10.1016/j.lungcan.2018.09.020. PMID: 30429018.
  • Hong JC, Spiegel DY, Havrilesky LJ, Chino JP. High Volume Providers and Brachytherapy Practice: A Medicare Provider Utilization and Payment Analysis. Brachytherapy. 2018 Nov - Dec;17(6):906-911. doi: 10.1016/j.brachy.2018.07.007. PMID: 30057292.
  • Chino F, Kamal A, LeBlanc T, Zafar Y, Suneja G, Chino J. Place of death for patients with cancer in the United States, 1999 through 2015: racial, age, and geographic disparities. Cancer. 2018 Oct 21. doi: 10.1002/cncr.31737. 
  • Spiegel D, Chino F, Moss H, Havrilesky, Chino J. Changes in Insurance Coverage for Cancer Patients Receiving Brachytherapy Before and After Enactment of the Affordable Care Act. Brachytherapy. 2018 Oct 20. pii: S1538-4721(18)30503-8. doi: 10.1016/j.brachy.2018.08.017.
  • Chino F, Peppercorn J, Rushing C, Nicolla J, Kamal A, Altomare I, Samsa G, Zafar SY. "Going for Broke": A Longitudinal Study of Patient-Reported Financial Sacrifice in Cancer Care. Journal of Oncology Practice. 2018 Sep;14(9):e533-e546. doi: 10.1200/JOP.18.00112
  • Chino F, Pollis K, Choi S, Salama J, Palta M. Stereotactic Body Radiation Therapy-induced Abscopal Effect on Hepatocellular Carcinoma after Treatment for Lung Cancer: A Case Report. Hepatology. 2018 Jun 11. doi: 10.1002/hep.30100. [Epub ahead of print]
  • Tandberg DJ, Oyekunle T, Lee WR, Wu Y, Salama JK, Koontz BF. Post-operative radiation therapy for prostate cancer: Comparison of conventional versus hypofractionated radiation regimens. IJROBP. 2018 Jun 1;101(2):396-405.
  • Chino F, Stephens SJ, Choi S, Marin D, Godfrey D, Czito B, Willett C, Palta M. The Role of External Beam Radiotherapy in the Treatment of Hepatocellular Cancer. Cancer. 2018 Apr 12. doi: 10.1002/cncr.31334
  • Hong JC, Ayala-Peacock DN, Lee J, Blackstock AW, Okunieff P, Sung MW, Weichselbaum RR, Kao J, Urbanic JJ, Milano MT, Chmura SJ, Salama JK. Classification for Long-term Survival in Oligometastatic Patients treated with Ablative Radiotherapy: A Multi-institutional Pooled Analysis. PLoS One. 2018 Apr 12; 13(4): e0195149. doi: https://doi.org/10.1371/journal.pone.0195149. PMID: 29649281.
  • Brownstein JM, Wisdom AJ, Castle KD, Mowery YM, Guida PM, Lee C, Tommasino F, La Tessa C, Scifoni E, Gao J, Luo L, Da Silva Campos L, Ma Y, Williams N, Jung S, Durante M, Kirsch DG. Characterizing the potency and impact of carbon ion therapy in a primary mouse model of soft tissue sarcoma. Molecular Cancer Therapeutics. 2018 Apr; 17(4).
  • Tandberg DJ, Ackerson BG, Tong BC, Kelsey CR. Surgery Versus Stereotactic Body Radiation Therapy for Stage I NSCLC: A Comprehensive Review. Cancer. 2018 Feb 15;124(4):667-678.
  • Nah SA, Ong CCP, Lie D, Marimuttu VJ, Hong J, Te-Lu Y, Low Y, Jacobsen AS. Unerstanding Experiences of Youth Growing Up with Anorectal Malformation or Hirschsprung's Disease to Inform Transition Care: A qualitative In-Depth Interview Study. Eur J Pediatr Surg. 2018 Feb:28(1):67-74. doi: 10.1055/s-0037-1605351. PMID: 28837998.
  • Chino F, Suneja G, Chino J. Image-guided HDR Brachytherapy for Pelvic Sidewall Recurrence of Endometrial Cancer. Practical Radiation Oncology. 2018. https://doi.org/10.1016/j.prro.2018.08.008
  • Song EJ, Jacobs C, Palta M, Willett CG, Yuan W, Czito BG. Evaluating Treatment Protocols for Rectal Squamous Cell Carcinomas: The Duke Experience and Literature Review. J Gastrointest Oncol. 2018. doi: 10.21037/jgo.2018.11.02.
  • Tandberg DJ, Willett CW, Czito B. Intraoperative radiation therapy. Precision Radiation Oncology. Rutgers University Press. 2018.
2017
  • Chino F, Suneja G, Moss H, Zafar Y, Havrilesky L, Chino J. Healthcare Disparities in Cancer Patietns Receiving Radiation: Changes in Insurance Status after medicaid Expansion under the Affordable Care Act. Int J Radiat Oncol Bio Phys. doi.org/10.1016/j.ijrobp.2017.1 [Article in Press] Published online Dec 13, 2017.
  • Fumiko Chino. My Unfortunate Introduction Into the Financial Toxicity of Cancer Care in America - March Forth. JAMA Oncol. Published online Dec 07, 2017. doi:10.1001/jamaoncol.2017.4436.
  • Jacobs C, Eickstaedt N, Driscoll C. Multiple Primary Synchronous Lung Cancer Diagnosed by Routine Low-Dose Computed Tomography Screening and Treated with Stereotactic Body Radiation Therapy. Gundersen Med J. 2017 Dec; 10(1), 61.
  • Jacobs C, Nashed D, Hagan B. Positional Cough: The Presenting Symptom of Left Atrial Myxoma. Gundersen Med J. 2017 Dec; 10(1), 50.
  • Song EJ, Hong JC, Czito BG. Tumor Lysis Syndrome Following Radiation Therapy in Metastatic Pancreatic Cancer: A Case Report. CRCP. 2017 Dec;4(4):22. doi:10.5430/crcp.v4n4p22.
  • Gensheimer M*, Hong JC*, Chang-Halpenny C, Eclov NCW, To J, Murphy JD, Wakelee HA, Neal J, Le QT, Hara WY, Quon A, Maxim PG, Graves EE, Olson MR, Diehn M, Loo BW. Mid-radiotherapy PET/CT for prognostication and detection of early progression in patients with stage III non-small cell lung cancer. Radiother Oncol. 2017 Aug 19. pii: S0167-8140(17)32514-8. doi: 10.1016/j.radonc.2017.08.007. PMID: 28830717. *Equal contributors.
  • Chino F, Peppercorn J, Rushing C, Kamal A, Altomare I, Samsa G, Zafar Y. “Going for Broke”: Out-of-Pocket Costs, Financial Distress and Underinsurance in Cancer Care. e-pub 2017 Aug 10. JAMA Oncology, doi:10.1001/jamaoncol.2017.2148
  • Hong JC, Rahimy E, Gross CP, Shafman T, Hu X, Yu JB, Ross R, Finkelstein SE, Dosoretz A, Park HS, Soulos PR, Evans SB. Radiation Dose and Cardiac Risk in Breast Cancer Treatment: An Analysis of Modern Radiotherapy Including Community Settings. Pract Radiat Oncol. 2017 Jul 20. pii: S1879-8500(17)30199-6. doi: 10.1016/j.prro.2017.07.005. Epub ahead of print. PMID: 28888675.
  • Huang J, Chen M, Whitley M, Kuo H, Xu E, Walens A, Mowery YM, Van Mater D, Eward W, Cardona D, Luo L, Ma Y, Lopez O, Nelson C, Robinson-Hamm J, Reddy A, Dave S, Gersbach C, Dodd R, Kirsch DG. Generation and comparison of CRISPR/Cas9 and Cre-mediated genetically engineered mouse models of sarcoma. Nature Communications. 2017 Jul; 8:15999.
  • Tandberg DJ, Kelsey CR, D’Amico TA, Crawford J, Chino JP, Tong BC, Ready NE, Wright A. Patterns of Failure Following Surgery for Non-Small Cell Lung Cancer Invading the Chest Wall. Clinical Lung Cancer. 2017 July; 18(4):259-265.
  • Rahimy E, Hong JC, Gross CP, Hu X, Shafman T, Conner H, Ross R, Dosoretz A, Evans SB. Increased number of beam angles is associated with higher cardiac dose in adjuvant fixed gantry intensity-modulated radiation therapy of left-sided breast cancer. Int J Radiat Oncol Biol Phys. 2017 Jun 27. pii: S0360-3016(17)33517-4. doi: 10.1016/j.ijrobp.2017.06.2451. Epub ahead of print. PMID: 28864402.
  • Ali M, Kaltenbrun E, Anderson GR, Stephens SJ, Arena S, Bardelli A, Counter CM, and Wood KC; Codon bias imposes a targetable limitation on KRAS-drive therapeutic resistance; Nature Communications; 8:15617; June 2017.
  • Bolton JL, Marinero S, Hassanzadeh T, Natesan D, Le D, Belliveau C, Mason S, Auten R, Bilbo S. Gestational Exposure to Air Pollution Alters Cortical Volume, Microglial Morphology, and Microglia-Neuron Interactions in a Sex-Specific Manner. Front Synaptic Neurosci. 2017;9:10. May 31 2017. doi:10.3389/fnsyn.2017.00010
  • Natesan D, Hong JC, Foote J, Sosa JA, Havrilesky L, Chino J. Increasing Utilization of Intensity Modulated Radiation Therapy in Vulvar Cancer: National Practice Patterns 2004-2012. J Radiat Oncol. 2017 May 18. DOI 10.1007/s13566-017-0312-9.
  • Hong JC, Foote J, Broadwater G, Gaillard S, Havrilesky LJ, Chino JP. Impact of chemotherapy and radiotherapy on management of early stage clear cell and papillary serous carcinoma of the uterus. Int J Gynecol Cancer. 2017 Apr 3. doi: 10.1097/IGC.0000000000000926. PMID: 28375927.
  • Mowery YM, Salama JK, Zafar SY, Moore HG, Willett CG, Czito BG, Hopkins MB, Palta M. Neoadjuvant long-course chemoradiation remains strongly favored over short-course radiotherapy by radiation oncologists in the United States. Cancer. 2017 Apr; 123(8):1434-1441.
  • Hong JC, Foote J, Broadwater G, Sosa J, Gaillard S, Havrilesky LJ, Chino JP. A data-derived treatment duration goal for cervical cancer: Should 8 weeks remain the goal in the era of concurrent chemoradiation? JCO Clinical Cancer Informatics 2017 Mar 28. doi: 10.1200/CCI.16.00072.
  • Natesan D, Hong JC, Foote J, Sosa JA, Gaillard S, Havrilesky L, Chino J. Primary vs. Preoperative Radiation for Locally Advanced Vulvar Cancer: A National Cancer Data Base (NCDB) analysis. Int J Gynecol Cancer. 2017 Mar 23. doi: 10.1097/IGC.0000000000000938. PMID: 28333840.
  • Jacobs C, Jafari ME. Early Results of Lung Cancer Screening and Radiation Dose Assessment by Low-Dose CT at a Community Hospital. Clin Lung Cancer. 2017 Feb 2. pii: S1525-7304(17)30040-2. http://dx.doi.org/10.1016/j.cllc.2017.01.011
  • Tandberg DJ, Holt T, Kelsey CR. Plasma Metabolites and risk of Radiation-induced Esophagitis: A Secondary Analysis from a Prospective Study, Anticancer Research. 2017 Feb; 37(2):719-726.
  • Hong JC, Salama JK. The expanding role of stereotactic body radiation therapy in oligometastatic solid tumors: what do we know and where are we going? Cancer Treat Rev. 2017 Jan;52:22-32. doi: 10.1016/j.ctrv.2016.11.003. PMID: 27886588.
  • Chino F, Willett C, Palta M, Czito, Chapter 15: Colorectal Cancer, Gastrointestinal Malignancies: A Practical Guide on Treatment Techniques, Springer International Publishing, 2017 DOI: 10.1007/978-3-319-64900-9
  • Spiegel D, Palta M, Uronis H. (2017). The Role of Chemotherapy and Radiation Therapy in the Management of Gastric Adenocarcinoma. Surgical Clinics of North America. 97(2):421-435.
  • Spiegel DY. Breast Cancer: Biology or Stage? Int J Radiat Oncol Biol Phys. 2017. 98(5):974-975.
  • Torok JA, Gu L, Tandberg DJ, Wang X, Harpole Jr. DH, Kelsey CR, Salama JK. Patterns of Distant Metastases Following Surgical Management of Non-Small Cell Lung Cancer, Clinical Lung Cancer. 2017; 18(1):57-70.
2016
  • Natesan D, Susko M, Havrilesky L, Chino J. Definitive Chemoradiotherapy for Vulvar Cancer. Int J Gynecol Cancer. Nove 2016;26(9):1699-1705. PMID: 27575629

  • Hong JC, Czito BG, Willett CG, Palta M. A current perspective on stereotactic body radiation therapy for pancreatic cancer. Onco Targets Ther. 2016 Oct 31;9:6733-6739. PMID: 27826200.
  • Stahl JM, Hong JC, Lester-Coll NH, Kann BH, Wilson LD, Higgins SA, Evans SB. Chest Wall Deformity in the Radiation Oncology Clinic. Anticancer Res. 2016 Oct;36(10):5295-5300. PMID: 27798891.
  • Stephens, SJ, Thomas, S, Rizzieri, DA, Horwitz, ME, Chao, NJ, Engemann, AM, Lassiter, M, and Kelsey, CR; Myeloablative conditioning and total body irradiation in AML: Balancing survival and pulmonary toxicity; Adv Radiat Oncol; 1(4); Oct-Dec 2016; 272-280.
  • Mowery YM and JK Salama. A Multidisciplinary Approach to Larynx Cancer: One Size Does Not Fit All. J Oncol Pract. 2016 Aug;12(8): 725-6.
  • Boyer MJ, Ricardi U, Ball D, and Salama JK. Ablative Approaches for Pulmonary Metastases. Thoracic Surgery Clinics 2016 Feb; 26(1): 19-34. doi: http://dx.doi.org/10.1016/j.thorsurg.2015.09.004
  • Evans MK, Sauer SJ, Nath S, Robinson TJ, Morse MA, Devi GR. X-linked Inhibitor of Apoptosis Protein Mediates Tumor Cell Resistance to Antibody-Dependent Cellular Cytotoxicity. Cell Death Disease. 2016 Jan 28;7:e2073.
  • Torok JA, Palta M, Willett CG, Czito BG. Nonoperative management of rectal cancer. Cancer. 2016, Jan 1, 122(1):34-41; Epub 2015.
  • Hong JC, Salama JK. Dose escalation for unresectable locally advanced non-small cell lung cancer: end of the line? Transl Lung Cancer Res 2016; 5(1): 126-133. doi: 10.3978/j.issn.2218-6751.2016. PMID: 26958507.
  • Moding EJ, Mowery YM and DG Kirsch. Opportunities for Radiosensitization in the SBRT Era. The Cancer Journal: The Journal of Principles & Practice of Oncology. 2016.
  • Mowery YM, Horton JK. “Preoperative partial breast.” Short Course Breast Radiotherapy: A Comprehensive Review of Hypofractionation, Partial Breast, and Intra-operative Irradiation, 1st edition. Editors Arthur DW, Vicini F, Wazer DE, Khan AJ. Springer International Publishing. 2016.
  • Mowery YM, Yoo S, and Blitzblau RC. “Chapter 30. Breast Cancer.” Treatment Planning in Radiation Oncology, 4th edition. Editors Khan F, Gibbons J, and Sperduto P. Lippincott Williams & Wilkins, Wolters Kluwer Health. 2016.
  • Soo MS, Jarosz JA, Wren AA, Soo AE, Mowery YM, Johnson KS, Yoon SC, Kim C, Hwang ES, Keefe FJ, Shelby RA. Imaging-Guided Core-Needle Breast Biopsy: Impact of Meditation and Music Interventions on Patient Anxiety, Pain, and Fatigue. Journal of the American College of Radiology. 2016.
  • Tandberg DJ, Osmond GW, Czito BG. Melanoma involving the surgical scar following surgery and craniospinal irradiation for childhood medulloblastoma: case report and literature review. Case Reports in Clinical Pathology. 2016;3(1):43-46.
2015
  • Olson AC, Coleman CN, Hahm SM, DeWeese TL, Shulman LN, Chabner BA, Chao N, Martei YM, Mundt AJ, Grover S. A Roadmap for a New Academic Pathway for Global Radiation Oncology. Int J Radiat Oncol Biol Phys. 2015 Nov; 93(3):493-496.
  • Robinson TJ, Dinan MA, Li Y, Lee WR, Reed SD. Longitudinal trends in costs of palliative radiation for metastatic prostate cancer. J Palliat Med. 2015 Nov; 18(11):933-9. Epub 2015 Aug 4.
  • Mowery YM and RC Blitzblau. The UK HeartSpare Study (Stage IB): Randomised comparison of a voluntary breath-hold technique and prone radiotherapy after breast conserving surgery: Bartlett FR, Colgan RM, Donovan EM, et al (Royal Marsden NHS Foundation Trust, Sutton, UK; et al) Radiother Oncol 114:66-72, 2014. Breast Diseases: A Year Book Quarterly. 2015 Oct; 26(3): 237–239.
  • Mowery YM. A Primer on Medical Education in the United States through the Lens of a Current Resident Physician. Journal of Thoracic Disease. 2015 Oct; 7(10).
  • Tandberg DJ, Craciunescu O, Kelsey CR. Radiation therapy for cutaneous T-cell lymphomas. Dermatol Clin. 2015 Oct;33(4):703-713.
  • Zafar SY, Chino F, Ubel PA, Rushing C, Samsa G, Altomare I, Nicolla J, Schrag D, Tulsky JA, Abernethy AP, Peppercorn JM. The utility of cost discussions between patients with cancer and oncologists. Am J Manag Care. 2015 Sep;21(9):607-15.
  • Grover S, Balogun OD, Yamoah K, Groen R, Shah M, Rodin D, Martei YM, Olson AC, Slone JS, Shulman LN, Coleman CN, Hahn SM. Training Global Oncologists: Addressing the Global Cancer Control Problem. Front Oncol. 2015 Apr 8;5:80. Pubmed ID 25905040.
  • Boyle JM, Tandberg DJ, Chino JP, D'Amico TA, Ready NE, Kelsey Cr. Smoking history predicts for increased risk of second primary lung cancer: A comprehensive analysis. Cancer. 2015 Feb 15; 121(4): 598-604.
  • Boyle J, Czito B, Willett C, Palta M. Adjuvant Radiation Therapy for Pancreatic Cancer: A Review of the Old and the New. J Gastrointest Oncol 2015. (Accepted for publication).
  • Boyle J, Lee WR. Surgery is Inappropriate for Very High Risk Prostate Cancer: Pro. Oncology (Williston Park) 2015. (Accepted for publication).
  • Salama JK, Palta M, Torok JA. The multidisciplinary management of early stage cervical esophageal cancer. In: Saba NF, El-Rayes B, eds. Esophageal Cancer: prevention, diagnosis and therapy. 1st ed. New York, NY: Springer International Publishing; 2015: 173-185.
  • Torok JA, Palta M, Willett CG, Czito BG. Principles of radiation therapy in rectal cancer. In Cai Q, Xu H, El-Rayes B, Kooby D, Landry J, eds. Gastrointestinal Malignancies: Diagnosis and Treatment. Singapore: World Scientific Publishing; 2015.
  • Torok JA, Perez BA, Czito BG, Willett CG, Yin F, Palta M. Cancers of the gastrointenstinal tract. In Khan FM, Gerbi BJ, Sperduto P eds. Treatment Planning in Radiation Oncology. 4th ed. Philadelphia, PA: Lippincott, Williams & Wilkins; 2015.
  • Torok JA, Wu Y, Prosnitz LR, Kim GJ, Beaven AW, Diehl LF, Kelsey CR. Low-dose consolidation radiation therapy for early stage unfavorable Hodgkin lymphoma. Intern J Radiat Oncol, Biol, Phys 2015; 92(1): 54-9 [PMID 25863754].
2014
  • Boyle J, Beaven A, Diehl, Prosnitz L, Kelsey C. Improving Outcomes in Advanced Diffuse Large B-cell Lymphoma: Systemic Approaches and Radiotherapy. Oncology (Williston Park). 2014 Dec 15;28(12).
  • Mowery YM and RC Blitzblau. Whole-breast radiation therapy: the long and short of it. Int J Radiat Oncol Biol Phys. 2014 Dec; 90(5):990-2.
  • Wattson DA, Tanguturi SK, Spiegel DY, Niemierko A, Biller BM, Nachtigall LB, Bussière MR, Swearingen B, Chapman PH, Loeffler JS, Shih HA. Outcomes of proton therapy for patients with functional pituitary adenomas. Int J Radiat Oncol Biol Phys. 2014 Nov 1;90(3):532-9.
  • Gill BS, Kim H, Houser C, Olson AC, Kelley J, Edwards RP, Comerci J, Sukumvanich P, Olawaiye AB, Huang M, Courtney-Brooks M, Beriwal S. Image-based three-dimensional conformal brachytherapy for medically inoperable endometrial carcinoma. Brachytherapy. 2014 Nov-Dec; 13(6):542-7. Pubmed ID 25127122.
  • Boyle J, Dorth, Craciunescu O, Steffey B, Light K, Chino J. Simultaneous Integrated Boost to Pelvic and Paraaortic Nodes from Cervical Cancer Improves the Dosimetric Therapeutic Ratio [abstract]. In: American Society for Radiation Oncology Annual Meeting 2014. September 14-17; San Francisco, CA; Fairfax, VA: ASTRO; 2014.
  • Boyle J, Craciunescu O, Steffey B, Cai J, Chino J. Safety, Feasibility, and Early Clinical Outcomes of Dose Escalation Using a Simultaneous Integrated Boost in Patients with Locally Advanced Gynecologic Malignancies. Gynecol Oncol. 2014 Sep 2.
  • Boyle J, Craciunescu O, Steffey B, Cai J, Chino J. Body mass index, dose to organs at risk during vaginal brachytherapy, and the role of three-dimensional CT-based treatment planning. Brachytherapy. 2014 Jul-Aug;13(4):332-6.
  • Bestvina CM, Zullig LL, Rushing C, Chino F, Samsa GP, Altomare I, Tulsky J, Ubel P, Schrag D, Nicolla J, Abernethy AP, Peppercorn J, Zafar SY. Patient-oncologist cost communication, financial distress, and medication adherence. J Oncol Pract. 2014 May;10(3):162-7. doi: 10.1200/JOP.2014.001406.
  • Boyer MJ, Salama JK, and Lee WR. Palliative radiotherapy for prostate cancer. Oncology 2014 Apr; 28(4): 306-312. PMID: 24839802.
  • Chino F, Peppercorn J, Taylor DH Jr, Lu Y, Samsa G, Abernethy AP, Zafar SY. Self-reported financial burden and satisfaction with care among patients with cancer. Oncologist. 2014 Apr;19(4):414-20. doi: 10.1634/theoncologist.2013-0374. Epub 2014 Mar 25.
  • Vivas EX, Wegner R, Conley G, Torok J, Heron DE, Kabolizadeh P, Burton S, Ozhasoglu C, Quinn A, Hirsch BE. Treatment outcomes in patients treated with CyberKnife radiosurgery for vestibular schwannoma. Otolaryngology & Neurotology 2014; 35(1): 162-70 [PMID 24335934.
  • Robinson TJ, and Koontz BF. Redox-Active Therapeutics. Chapter: Oxidative Stress and Erectile Dysfunction in the Treatment of Prostate Cancer. Springer. Editors: Batinic-Haberle, Reboucas, Spasojevic, St.Clair, and Watner. 2014.
  • Torok JA, Czito BG, Willett CG, Palta M. Future of radiotherapy delivery in rectal cancer-European and US approaches. Oncology & Hematology Review 2014; 10(2): 139-143 [not indexed in pubmed].
  • Torok JA, Palta M, Czito BG, Willett CG. Intraoperative radiotherapy in the treatment of gastrointestinal malignancies. Translational Cancer Research 2014; 3(6): 537-540 [not indexed in pubmed].
2013
  • Tandberg DJ, Gee NG, Chino JP, D’Amico TA, Berry MF, Ready NE, Coleman RE, Higgins KA, Kelsey CR. Are Discordant PET and Pathological Assessments of the Mediastinum in Non-Small Cell Lung Cancer Significant? J Thorac Cardiovasc Surg. 2013 Oct;146(4):796-801.
  • Boyle J, Dorth, Craciunescu O, Steffey B, Light K, Chino J. Initial Safety and Feasibility of Dose Escalation Using a Simultaneous Integrated Boost in Patients With Locally Advanced Gynecologic Malignancies [abstract]. In: American Society for Radiation Oncology Annual meeting; 2013. September 22-25; Atlanta, GA; Fairfax, VA: ASTRO; 2013
  • Homa N, Salinas-Mondrigan R, Forte E, Robinson TJ, Garcia-Blanco MA and Luftig MA. Epstein-Barr virus induces global changes in cellular mRNA isoform usage important for the maintenance of latency. Journal of Virology. 2013 Nov; 87(22):122291-301. Epub 2013 Sep 11.
  • Donnelly E, Refaat T, Gentile M, Boyle J, Helenowski I, Rademaker A, Lurain J, Schink J, Singh D, Strauss JB, Small W Jr. Evaluation of Outcomes in Patients With Carcinoma of the Cervix Treated With Concurrent Radiation and Cisplatin Versus Cisplatin/5-FU Compared With Radiation Alone. Am J Clin Oncol. 2013 Jul 24. [Epub ahead of print].
  • Coen JJ, Paly JJ, Niemierko A, Kaufman DS, Heney NM, Spiegel DY, Efstathiou JA, Zietman AL, Shipley WU. Nomograms predicting response to therapy and outcomes after bladder-preserving trimodality therapy for muscle-invasive bladder cancer. Int J Radiat Oncol Biol Phys. 2013 Jun 1; 86(2):311-6.
  • Cabrera AR, Cuneo KC, Desjardins A, Sampson JH, McSherry F, Herndon JE 2nd, Peters KB, Allen K, Hoang JK, Chang Z, Craciunescu O, Vredenburgh JJ, Friedman HS, Kirkpatrick JP. Concurrent Stereotactic Radiosurgery and Bevacizumab in Recurrent Malignant Gliomas: A Prospective Trial. Int J Radiat Oncol Biol Phys. 2013 May 29. [Epub ahead of print]
  • Cuneo KC, Mito JK, Javid MP, Ferrer JM, Kim Y, Lee WD, Bawendi MG, Brigman BE, Kirsch DG. Imaging primary mouse sarcomas after radiation therapy using cathepsin-activatable fluorescent imaging agents. Int J Radiat Oncol Biol Phys. 2013 May 1;86(1):136-142.
  • Willett CG, Czito BG, Palta M. ACT II: treatment of anal cancer comes full circle. Lancet Oncol. 2013 Apr 8. doi:pii: S1470-2045(13)70121-9. Epub ahead of print].
  • Dorth JA, Patel PR, Broadwater G, Brizel DM. Incidence and risk factors of significant carotid artery stenosis in asymptomatic survivors of head and neck cancer after radiotherapy. Head Neck. 2013 Apr 2. doi: 10.1002/hed.23280. [Epub ahead of print]
  • Kelsey CR, Fornili M, Ambrogi F, Higgins K, Boyd JA, Biganzoli E, Demicheli R. Metastasis Dynamics for Non-Small-Cell Lung Cancer: Effect of Patient and Tumor-Related Factors. Clin Lung Cancer. 2013 Mar 15. doi:pii: S1525-7304(13)00028-4. 10.1016/j.cllc.2013.01.002. [Epub ahead of print]
  • Zhong J, Palta M, Willett CG, McCall SJ, Bulusu A, Tyler DS, White RR, Uronis HE, Pappas TN, Czito BG. The role of local excision in invasive adenocarcinoma of the ampulla of Vater. J Gastrointest Oncol. 2013 Mar;4(1):8-13.
  • Pepek JM, Chino JP, Willett CG, Palta M, Blazer Iii DG, Tyler DS, Uronis HE, Czito BG. Preoperative chemoradiotherapy for locally advanced gastric cancer. Radiat Oncol. 2013 Jan 4;8:6.
  • Pepek JM, Willett CG, Czito BG. Technical considerations in radiation therapy for gastroesophageal junction cancer. Semin Radiat Oncol. 2013 Jan;23(1):51-59.
  • Perez BA, Ghafoori AP, Lee CL, Johnston SM, Li Y, Moroshek JG, Ma Y, Mukherjee S, Kim Y, Badea CT, Kirsch DG. Assessing the radiation response of lung cancer with different gene mutations using genetically engineered mice. Front Oncol. 2013;3:72.
  • Wattson DA, Tanguturi SK, Spiegel DY, Niemierko BMK, Biller LB, Nachtigall LB, Swearingen B, Chapman PH, Loeffler JS, Shish HA. Outcomes of Proton Radiation Therapy for Patients with Functional Pituitary Adenomas. Int J Radiat Oncol Biol Phys. 2013. 87 (2):S264.
2012
  • Oh DS, Adamson DC, Kirkpatrick JP. Targeted radiotherapy for malignant gliomas. Curr Drug Discov Technol. 2012 Dec;9(4):268-79.
  • Mito JK, Ferrer JM, Brigman BE, Lee CL, Dodd RD, Eward WC, Marshall LF, Cuneo KC, Carter JE, Ramasunder S, Kim Y, Lee WD, Griffith LG, Bawendi MG, Kirsch DG. Intraoperative detection and removal of microscopic residual sarcoma using wide-field imaging. Cancer. 2012 Nov 1;118(21):5320-30
  • Cuneo KC, Riedel RF, Dodd LG, Harpole DH, Kirsch DG. Pathologic complete response of a malignant peripheral nerve sheath tumor in the lung treated with neoadjuvant ifosfamide and radiation therapy. J Clin Oncol. 2012 Oct 1;30(28):291-293.
  • Cuneo KC, Dash RC, Wilke LG, Horton JK, Koontz* BF. Risk of invasive breast cancer and ductal carcinoma in-situ in women with atypical papillary lesions of the breast. The Breast Journal 2012 Sep;18(5):475-478.
  • Patel PR, Salama JK. Reirradiation for recurrent head and neck cancer. Expert Rev Anticancer Ther. 2012 Sep;12(9):1177-89.
  • Sioshansi S, Ehdaivand S, Cramer C, Lomme M, Price L and Wazer DE. Triple Negative Breast Cancer is Associated with an Increased Risk of Residual Invasive Carcinoma after Lumpectomy. Cancer 2012, August 15; 118(16): 3893-8, Epub, Jan 3, 2012.
  • Lee C-L, Moding EJ, Cuneo KC, Li Y, Sullivan JM, Mao L, Washington I, Jeffords LB, Rodrigues RC, Ma Y, Das S, Kontos CD, Yongbaek K, Rockman HA, Kirsch DG. p53 Functions in Endothelial Cells to Prevent Radiation-Induced Myocardial Injury in Mice. Science Signaling 2012 Jul 24;5(234):ra52.
  • Patel P, Lee WR. Radiotherapy following radical prostatectomy. Expert Rev Anticancer Ther. 2012 Jul;12(7):973-9. doi: 10.1586/era.12.66. Review.
  • Robinson TJ, Forte E, Salinas-Mondrigan R, Puri S, Marengo M, Garcia-Blanco MA and Luftig MA. SplicerEX: a tool for the automated detection and classification of mRNA changes from conventional and splice-sensitive microarray expression data. RNA 2012 Aug;18(8):1435-45. Epub 2012 Jun 26.
  • Cabrera, A.R., Cuneo, K.C., Vredenburgh, J.J., Sampson, J.H., Kirkpatrick, J.P. Stereotactic radiosurgery and bevacizumab for recurrent glioblastoma multiforme. Journal of the National Comprehensive Cancer Network, 2012 Jun 1;10(6):695-699.
  • Higgins KA, Chino JP, Berry M, Ready N, Boyd J, Yoo DS, Kelsey CR. Local failure in resected N1 lung cancer: implications for adjuvant therapy. Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):727-733.
  • Cuneo KC, Zagar TM, Brizel DM, Yoo DS, Hoang JK, Chang Z, Wang Z, Yin FF, Das SK, Green S, Ready N, Bhatti MT, Kaylie DM, Becker A, Sampson JH, Kirkpatrick JP. Stereotactic radiotherapy for malignancies involving the trigeminal and facial nerves. Technol Cancer Res Treat. 2012 Jun;11(3):221-228.
  • Patel PR, Yoo S, Broadwater G, Marks LB, Miles EF, D'Amico TA, Harpole D, Kelsey CR. Effect of increasing experience on dosimetric and clinical outcomes in the management of malignant pleural mesothelioma with intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):362-368.
  • Palta M, Patel P, Broadwater G, Willett C, Pepek J, Tyler D, Zafar SY, Uronis H, Hurwitz H, White R, Czito B. Carcinoma of the ampulla of Vater: patterns of failure following resection and benefit of chemoradiotherapy. Ann Surg Oncol. 2012 May;19(5):1535-1540.
  • Cuneo KC, Vredenburgh JJ, Sampson JH, Reardon DA, Desjardins A, Peters KL, Kirkpatrick JP. Safety and efficacy of stereotactic radiosurgery and adjuvant bevacizumab in patients with recurrent malignant gliomas. Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):2018-2024.
  • Dinan MA, Robinson TJ, Zagar TM, Scales CD Jr, Curtis LH, Reed SD, Lee WR, Schulman KA. Changes in initial treatment for prostate cancer among medicare beneficiaries, 1999-2007. Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):e781-6.
  • Dinan MA, Robinson TJ, Zagar TM, Scales CD, Curtis LH, Reed SD, Schulman KA, Lee RW. Changes in the initial Treatment of Prostate Cancer among Medicare Beneficiaries 1999-2007. Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5): e781-6. Epub 2012 Feb 11.
  • Higgins KA, Hoang JK, Roach MC, Chino J, Yoo DS, Turkington TG, Brizel DM. Analysis of pretreatment FDG-PET SUV parameters in head-and-neck cancer: tumor SUVmean has superior prognostic value. Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):548-553.
  • Higgins, K. A., Jenny K. Hoang, Michael C. Roach, Junzo Chino, David S. Yoo, Timothy G. Turkington, David M Brizel. Analysis of Pretreatment FDG-PET SUV Parameters in Head-and-Neck Cancer: Tumor SUVmean has Superior Prognostic Value. Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):548-53.
  • Zagar TM, White RR, Willett CG, Tyler DS, Papavassiliou P, Papalezova KT, Guy CD, Broadwater G, Clough RW, Czito BG. Resected Pancreatic Neuroendocrine Tumors: Patterns of Failure and Disease-Related Outcomes With or Without Radiotherapy. Int J Radiat Oncol Biol Phys. 2012 Jan 21.
  • Simmons LA, Dinan MA, Robinson TJ, Snyderman R. Personalized medicine is more than genomic medicine: confusion over terminology impedes progress towards personalized healthcare. Future Medicine. 2012, Jan 9(1): 85-91.
  • Palta M, S Yoo, J Adamson, J Horton. Preoperative Single Fraction Partial Breast Radiotherapy for Early Stage Breast Cancer. Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):37-42.
  • Roach MC, Turkington TG, Higgins KA, Hawk TC, Hoang JK, Brizel DM. FDG-PET assessment of the effect of head and neck radiotherapy on parotid gland glucose metabolism. Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):321-6.
  • Cho AH, Jiang X, Mann DM, Kawamoto K, Robinson TJ, Wang N, McCarthy JJ, Woodward M, Ginsburg GS. A more rapid approach to systematically assessing published associations of genetic polymorphisms and disease risk: type 2 diabetes as a test case. Comparative Effectiveness Research. 2012 Jan 2012(2): 1-20.
  • Dorth JA, Prosnitz LR, Broadwater G, Diehl LF, Beaven AW, Coleman RE, Kelsey CR. Impact of Consolidation Radiation Therapy in Stage III-IV Diffuse Large B-cell Lymphoma with Negative Post-Chemotherapy Radiologic Imaging. Int J Radiat Oncol Biol Phys. 2012 84( 3):762-767.
  • Efstathiou JA, Spiegel DY, Shipley WU, Heney NM, Kaufman DS, Niemierko A, Coen JJ, Skowronski RY, PalyJJ, McGovern FJ, Zietman AL. Long-Term Outcomes of Selective Bladder Preservation by Combined-Modality Therapy for Invasive Bladder Cancer: The MGH Experience. European Urology. 2012. 61(4):705-711
  • Patel PR, Yoo DS, Niibe Y, Urbanic JJ, Salama JK. A call for the aggressive treatment of oligometastatic and oligo-recurrent non-small cell lung cancer. Pulm Med. 2012;2012:480961.
  • Yue, J., Yang, Y., Cabrera, A.R., Sun, X., Zhao, S., Xie, P., Zheng, J., Ma, L., Fu, Z., Yu, J. Measuring tumor hypoxia with 18F-FETNIM PET in esophageal squamous cell carcinoma: a pilot clinical study. Diseases of the Esophagus 2012 25(1):54-61.
2011
  • Diavolitsis V, Shirazi H, Boyle J, Hayes J. Residents' educational needs during transition into radiation oncology residency. J Am Coll Radiol. 2011 Nov;8(11):785-8.
  • Higgins KA, Chino JP, Ready N, Onaitis MW, Berry MF, D'Amico TA, Kelsey CR. Persistent N2 disease after neoadjuvant chemotherapy for non-small-cell lung cancer. J Thorac Cardiovasc Surg. 2011 Nov;142(5):1175-9.
  • Boyle J, Donnelly E, Lurain J, Schink J, Singh D, Gentile M,Weitner B, Strauss J, Small W. Patterns of Recurrence After Definitive Radiation Therapy for Locoregionally-Confined Cervical Cancer. In: American Society for Radiation Oncology Annual meeting; 2011. October 2-6; Miami, FL; Fairfax, VA: ASTRO; 2011.
  • Palta M, Willett C, Czito B. Role of radiation therapy in patients with resectable pancreatic cancer. Oncology (Williston Park). 2011 Jul;25(8):715-21, 727. Review.
  • Boyle, J., Diavolitsis, Small, W. Role of Radiation Therapy in Uterine-confined Endometrial Carcinoma. Pract Radiat Oncol. 2011 Jul-Sep;1(3):196-203.
  • Pepek JM, Chino JP, Marks LB, D'Amico TA, Yoo DS, Onaitis MW, Ready NE, Hubbs JL, Boyd J, Kelsey CR. How well does the new lung cancer staging system predict for local/regional recurrence after surgery?: A comparison of the TNM 6 and 7 systems. J Thorac Oncol. 2011 Apr;6(4):757-761.
  • Diavolitsis, V., Rademaker. A., Boyle, J., Kang, J., Kiel, K., Mulcahy, M., Small, W., Change in Creatinine Clearance over time Following Upper Abdominal Irradiation: A Dose Volume Histogram Multivariate Analysis. Am J Clin Oncol. 2011 Feb;34(1):53-7.
  • Dorth JA, Chino JP, Prosnitz LR, Diehl LF, Beaven AW, Coleman RE, Kelsey CR. The impact of radiation therapy in patients with diffuse large B-cell lymphoma with positive post-chemotherapy FDG-PET or gallium-67 scans. Ann Oncol. 2011 Feb;22(2):405-410.
  • Miller HB, Robinson TJ, Gordan R, Hartemink AJ, Garcia-Blanco MA. Identification of Tat-SF1 cellular targets by exon array analysis reveals dual roles in transcription and splicing. RNA 2011 Apr;17(4): 665-74. Epub 2011 Jan 31.
  • Cabrera AR, Kelsey, C.R., Marks, L.B. Small cell lung cancer. British Medical Journal (Best Practice). 2011.
  • Cabrera A.R., Lee W.R., Madden R., Sims E., Hoang J.K., White L.E., Marks L.B., Chino J.P. Incorporating gross anatomy education into radiation oncology residency: A two year curriculum with evaluation of resident satisfaction. Journal of the American College of Radiology. 2011 8:335-340.
  • Palta M, Riedel RF, Vredenburgh JJ, Cummings TJ, Green S, Chang Z, Kirkpatrick JP. Primary meningeal rhabdomyosarcoma. Sarcoma. 2011;2011:312802.
  • Palta M, WR Lee. The Development of Oncology Treatment Guidelines: An Analysis of the National Guidelines Clearinghouse. Practical Radiation Oncology; 2011;1:33­37.

Resident Presentations

2020
2019
  • Jacobs C, Barak I, Jung SH, Rocke D, Kahmke R, Suneja G, Mowery YM. Prediction Model to Estimate Overall Survival Benefit of Postoperative Radiotherapy for Resected Major Salivary Gland Cancers. Oral presentation and monetary award for best clinical and population science abstract at Duke Cancer Institute Scientific Retreat. 2019 Oct 25; Durham, NC.
  • Jacobs C, Barbour AB, Suneja G, Williamson H, Floyd SR, Torok JA, Kirkpatrick JP. Whole Brain Radiotherapy Practice Patterns in the Era of Stereotactic Radiosurgery. Digital poster presentation at American Society for Radiation Oncology (ASTRO) 61st Annual Meeting. 2019 Sept 17; Chicago, IL.
  • Jacobs C, Kahmke R, Rocke D, Barak I, Jung SH, Suneja G, Mowery YM. Nomogram to Predict Survival Benefit of Postoperative Radiotherapy for Major Salivary Gland Cancers. Oral presentation at American Society for Radiation Oncology (ASTRO) 61st Annual Meeting. 2019 Sept 17; Chicago, IL.
  • Jacobs C, Gao J, Wang X, Mehta K, Salama JK, Torok JA, Kelsey CR. Nomogram Predicting Overall Survival Benefit of Stereotactic Ablative Radiotherapy for Early Stage Non-Small Cell Lung Cancer. Poster presentation at IASLC World Congress on Lung Cancer. 2019 Sept 8; Barcelona, Spain.
  • Jacobs C, Woldemichael K, Williamson H, Abisheva Z, Howell E, Abdelgadir J, Dechant C, Floyd SR, Fecci P, Kirkpatrick JP, Adamson J, Torok JA. Single- Versus Multi-Fraction Stereotactic Radiosurgery for Brainstem Metastases. Poster presentation at the Society for Neuro-Oncology’s Inaugural Conference on Brain Metastases. 2019 Aug 16; New York, NY.
  • Jacobs C, Chodavadia P, Wang F, Havrilesky L, Chino JP, Suneja G. United States Practice Patterns and Comparative Effectiveness of GOG 249 Arms. Oral presentation at American Brachytherapy Society (ABS) Annual Meeting. 2019 Jun 15; Miami, FL.
  • Jacobs C, Suneja G, Barak I, Mehta K, Agassi A, Brizel DM, Mowery YM. Utilization of Brachytherapy for Early Stage Oral Cavity Cancers in the United States. Oral presentation at American Brachytherapy Society (ABS) Annual Meeting. 2019 Jun 13; Miami, FL.
  • Barbour AB, Jacobs C, Suneja G, Floyd SR, Torok JA, Kirkpatrick JP. U.S. Radiotherapy Practice Patterns for Brain Metastases in the Era of Stereotactic Radiosurgery. Oral presentation at International Stereotactic Radiosurgery Society Congress. 2019 Jun 10; Rio de Janeiro, Brazil.
  • Jacobs C, Woldemichael K, Abisheva Z, Abdelgadir J, Howell E, Dechant C, Floyd SR, Torok JA, Adamson J, Fecci P, Kirkpatrick JP. Stereotactic Radiosurgery in 1-5 Fractions for Brainstem Metastases: Radiobiologic Rationale and Logistics Informing Clinical Practice. Poster presentation at International Stereotactic Radiosurgery Society Congress. 2019 Jun 9; Rio de Janeiro, Brazil.
  • Hong JC, Hauser ER, Redding TS, Sims KJ, Gellad ZF, O'Leary M, Madison A, Qin X, Weixx DG, Bullard AJ, Williams CD, Sullivan B, Lieberman DA, Provenzale D. Characterization of temporal relationships of comorbidities developed following cancer diagnoses in veterans (Abstract). American Society of Clinical Oncology Annual Meeting, Chicago, June 2019.
  • Chino F, Stephens SJ, Price J, Salama J. Increasing Radiation Knowledge in non-Radiation Oncologists: Improving Multidisciplinary Cancer Care Through Radiation Oncology Education Project. ROECSG Spring Symposium, Chicago, May 2019.
  • Chino F, Health Services Research: Finanical Toxicity and Cancer Treatment in America. Florida Socitty of Clinical Oncology, Spring Session, Orlando, FL, Apr 2019.
  • Chino F, Health Services Research: Finanical Toxicity and Cancer Treatment in America. North Carolina Survivorship Summit, Raleigh, NC, Apr 2019.
  • Jacobs C, Rocke D, Kahmke R, Williamson H, Suneja G, Mowery YM. Adjuvant Radiotherapy is Associated with Improved Overall Survival for Resected Alveolar Ridge Squamous Cell Carcinoma with Adverse Pathologic Features. Poster presentation at National Comprehensive Cancer Network (NCCN) Annual Conference. 2019 Mar 22; Orlando, FL.
  • Jacobs C, Gao J, Wang X, Ready NE, Clarke JM, Tong B, Kelsey CR, Suneja G, Torok JA. Definitive Radiotherapy for Inoperable Stage IIB Non-Small Cell Lung Cancer: Patterns of Care and Comparative Effectiveness Analyses Using the National Cancer Database. Poster presentation at Multidisciplinary Thoracic Cancers Symposium. 2019 Mar 14; San Diego, CA.
  • Jacobs C, Trotter J, Palta M, Wu Y, Willett CG, Lee WR, Czito BC. Multi-Institutional Analysis of Synchronous Prostate and Rectosigmoid Cancers. Poster presentation at Genitourinary Cancers Symposium. 2019 Feb 14; San Francisco, CA.
  • Chino F, Health Services Research: Finanical Toxicity and Cancer Treatment in America. Kansas Cancer Partnership, Topeka, Kansas. Jan 2019.
2018
  • Brownstein J, Wisdom A, Mower Y, Castle K. Lee CL, Luo L, Williams N, Ma Y, Da Silva-Campos L, Kirsch D. Calculating the RBE of carbon ion radiotherapy in a primary mouse model of sarcoma. International symposium on ion therapy (oral presentation). November 2018.
  • Chino F, Health Services Research: Finanical Toxicity and Cancer Treatment in America. 19th Annual Meeting of the Society of Urologic Oncology, Phoenix, AZ. November 2018.
  • Hong JC, Hauser ER, Redding TS, Sims K, Gellad Z, O’Leary M, Hyslop T, Madison A, Qin X, Weiss D, Bullard AJ, Thomas R, Williams C, Sullivan B, Johnson M, Turner M, Lieberman D, Provenzale D. Network analysis of chronological relationships of comorbidities in veterans from a prospective screening colonoscopy trial (Poster presentation). American Medical Informatics Association (AMIA) 2018 Annual Symposium, San Francisco, November 2018.
  • Hong JC, Niedzwiecki D, Palta M, Tenenbaum JD. Natural language processing to identify patient symptoms during and prior to cancer therapy (Poster presentation). American Medical Informatics Association (AMIA) 2018 Annual Symposium, San Francisco, November 2018.
  • Hong JC, Willett CG. Rectal Cancer with Synchronous Metastasis. 2018 Gastrointestinal Oncology Conference. International Society of Gastrointestinal Oncology. Arlington, VA. November 2018.
  • Jacobs C, Carpenter DJ, Chino JP. Changes on Mid-Treatment FDG-PET/CT for Cervical Cancer Treated with Chemoradiotherapy Are Associated with Prognosis. Oral presentation at American Society for Radiation Oncology (ASTRO) 60th Annual Meeting. 2018 Oct 24; San Antonio, TX.
  • Jacobs C, Carpenter DJ, Hong JC, Chino JP. Inclusion of Subjects with Internally Inconsistent or Anomalous Data within the National Cancer Database Significantly Alters Survival Results. Oral presentation at American Society for Radiation Oncology (ASTRO) 60th Annual Meeting. 2018 Oct 24; San Antonio, TX.
  • Chino F, The Impact of the Affordable Care Act on Cancer Care for Underserved Communities: The Good, The Bad, and the Unknown. 60th Annual Meeting of the American Society for Radiation Oncology, San Antonio. October 2018.
  • Hong J, Niedzwiecki D, Palta M, Tenenbaum J. Predicting emergency visits and hospital admissions in radiation and chemoradiation: Performance of a pre-treatment machine learning algorithm on different disease sites in an internal validation cohort (Oral presentation). 60th Annual Meeting of the American Society for Radiation Oncology (ASTRO), San Antonio. October 2018.
  • Chino F, Kamal A, Chino J. Opioid-associated deaths in patients with cancer: A population study of the opioid epidemic over the past 10 years. ASCO Quality Care Symposium, Phoenix. Sept. 2018.
  • Chino F, Health Services Research: Finanical Toxicity and Cancer Treatment in America. Iowa Oncology Society, Annual Conference, Iowa City, IA, Sept. 2018.
  • Chino F, Kamal A, Chino J, LeBlanc T. Comprehensive evaluation of place of death for patients with hematological malignancies, 1999-2015. Poster presentation at American Society of Clinical Oncology Annual Meeting, Chicago, June 2018.
  • Hong J. A Learning Healthcare System: Machine Learning-Based Clinical Decision Tools (Oral presentation). American Association of Physicists in Medicine (AAPM) Practical Big Data Workshop 2018. Ann Arbor. June 2018.
  • Hong JC, Boyer MJ, Spiegel DY, Williams CD, Tong BC, Shofer SL, Moravan MJ, Kelley MJ, Salama JK. Improved Survival of Small Cell Lung Cancer in the Veterans Health Administration from 2000-2010: Association with Increasing Utilization of PET Staging (Abstract). American Society of Clinical Oncology Annual Meeting, Chicago. June 2018.
  • Hong JC, Havrilesky LJ, Chino JP. High Volume Providers and Brachytherapy Practice: An Analysis of the Medicare Provider Utilization and Payment Data Set (Oral presentation). American Brachytherapy Society 2018 Annual Meeting, San Francisco. June 2018.
  • Spiegel D, Chino F, Moss H, Zafar Y, Havrilesky L, Chino J. "Changes in Insurance Coverage for Cancer Patients Receiving Brachytherapy Before and AFter Enactment of the Affordable Care Act". American Brachytherapy Society Annual Conference, San Francisco. June 2018.
  • Sullivan B, Redding T, Hauser ER, Gellad Z, Qin X, Weiss D, O’Leary M, Madison A, Bullard J, Hyslop T, Sims K, Thomas R, Williams C, Hong J, Johnson M, Turner M, Provenzale D, Lieberman D. Missed Lesions and Appropriate Follow-Up of Screening and Surveillance (Oral presentation). Digestive Disease Week 2018, Washington, DC. June 2018.
  • Chino, F. “Financial Toxicity and Cancer Treatment”. Indiana Oncology Society Annual Conference, Indianapolis, IN. April 2018.
  • Spiegel DY, Hong JC, Oyekunle T, Lee WR, Koontz BF, Salama JK. A nomogram for testosterone recovery following combined androgen deprivation therapy and radiation therapy for prostate cancer (Oral presentation). European Society for Radiotherapy and Oncology (ESTRO) 37, Barcelona. April 2018.
  • Hong JC, Palta M, Tenenbaum JD. Machine learning on EHR data for prediction of emergency visits and hospitalization during cancer radiotherapy (Poster presentation). American Medical Informatics Association (AMIA) 2018 Informatics Summit, San Francisco, March 2018.
  • Spiegel D, Boyer M, Hong JC, Williams CD, Kelley MJ, Rangwala FA, Salama JK, Palta M. Role of Adjuvant Chemotherapy Following Chemoradiation and Surgery for Locoregionally Advanced Rectal Cancer: A Veterans Health Administration Analysis (Poster presentation). 2018 Gastrointestinal Cancers Symposium, San Francisco. January 2018.
2017
  • Spiegel DY, Boyer MJ, Hong JC, Williams CD, Kelley MJ, Salama JK, Palta M. Nonoperative Management for Locally Advanced Rectal Cancer in the Veterans Health Administration. Accepted for the Best of ASTRO Meeting. 2017 Nov 10-11; Miami, FL. Presentation #144.
  • Chino F, Suneja G, Moss H, Zafar Y, Havrilesky L, Chino J. “Healthcare Disparities in Cancer Patients Receiving Radiation: Changes in Insurance Status after Medicaid Expansion under the Affordable Care Act.”. 5th Annual Duke Cancer Institute Scientific Retreat, Durham. 2017 Oct. 27. [Platform Presentation]
  • Brownstein JM, Wisdom A, Mowery Y, Castle K, Rusek A, Luo L, Williams N, Guida P, Ma Y, Lee CL, Da Silva Campos L, Kirsch D. Duke Cancer Institute. Calculating the RBE of carbon ion radiotherapy in a primary mouse model of sarcoma. Radiation Research Annual Conference (2017 poster). October 2017.
  • Ackerson BG, Hong JC, Kelsey CR. SBRT Versus Sublobar Resection for Stage I NSCLC (Poster presentation). 59th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, San Diego, September 2017.
  • Brownstein JM, Rusek A, Rossalot R, Castle K, Mowery Y, Wisdom A, Williams N, Luo L, Kirsch D. Duke Cancer Institute, ASTRO Conference (2017) High LET carbon ion radiotherapy in the treatment of a primary mouse sarcoma model at the NASA Space Research Laboratory. ASTRO annual meeting (2017 poster). September 2017.
  • Chino F, Castellar E, Schild M, Blitzblau R, Suneja G, Duffy E, Broadwater G, Horton J Pathologic Response and Acute Toxicity: Planned Interim Analysis of the Phase II NeoRT Trial Evaluating Preoperative Single Fraction Partial Breast Radiotherapy in Early Stage Breast Cancer. (Poster presentation). 59th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, San Diego. September 2017.
  • Chino F, Hong J, Torok J, Chino J, Suneja G. IMRT Utilization Rates for Treatment of Intact Cervical Cancer, A National Cancer Database Analysis (Poster presentation). 59th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, San Diego, September 2017.
  • Chino F, Suneja G, Moss H, Zafar Y, Havrilesky L, Chino J. Healthcare Disparities in Cancer Patients Receiving Radiation: Changes in Insurance Status after Medicaid Expansion under the Affordable Care Act. (Oral Presentaton, Late Breaking Abstract Session). 59th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, San Diego. September 2017.
  • Hong JC, Ayala-Peacock DN, Lee J, Blackstock AW, Okunieff P, Sung MW, Weichselbaum RR, Kao J, Urbanic JJ, Milano MT, Chmura SJ, Salama JK. Predicting for Long-term Survival in Oligometastatic Patients treated with Ablative Radiotherapy: A Multi-institutional Pooled Analysis (Electronic poster discussion). 59th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, San Diego, September 2017.
  • Jacobs C, Hong JC, Havrilesky L, Sosa JA, Chino JP. Quality of reported radiation data as recorded in the NCDB for node positive uterine cancer. Poster presented at American Society for Radiation Oncology (ASTRO) 59th Annual Meeting. September 2017; San Diego, CA.
  • Lafata K, Cai J, Wang C, Hong J, Kelsey C, Yin FF. Sensitivity of Radiomic Features to Acquisition Noise and Respiratory Motion (Oral presentation). 59th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, San Diego, September 2017.
  • Spiegel DY, Boyer MJ, Hong JC, Kelley M, Salama JK, Palta M. Non-operative Management for Locally Advanced Rectal Cancer in the Veterans Affairs System (Oral presentation). 59th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, San Diego, September 2017.
  • Tandberg DJ, Cui Y, Hong JC, Ackerson B, Czito B, Willett CW, Palta M. Intra-treatment FDG-PET Imaging to Predict Radiation Induced Esophagitis during Chemoradiotherapy for Esophageal Cancer. Accepted poster presentation, 59th annual meeting American Society of Radiation Oncology, San Diego, September 2017.
  • Tandberg DJ, Lee WR, Salama J, Koontz B. Toxicity and Biochemical Outcomes of Hypofractionated Intensity Modulated Post-Operative Radiation Therapy for Prostate Cancer. Accepted poster presentation, 59th annual meeting American Society of Radiation Oncology, San Diego, September 2017.
  • Lafata K, Cai J, Wang C, Hong J, Kelsey C, Yin FF. Sensitivity of Radiomic Features to Acquisition Noise and Respiratory Motion (Oral presentation). American Association of Physicists in Medicine 2017 Meeting. August 2017.
  • Mowery YM. Impact of Mutational Load and Tumor Transplantation on Response to Radiotherapy and Immune Checkpoint Inhibitors. 2017 Immunotherapy Workshop, Incorporating Radiation Oncology into Immunotherapy. Oral presentation. Co-Sponsored by American Society for Radiation Oncology (ASTRO), National Cancer Institute (NCI) and Society for Immunotherapy of Cancer (SITC). June 15, 2017. Bethesda, MD.
  • Yin FF, Lafata K, Hong JC, Kelsey CR. Effects of Motion on Radiomics Analysis of Thoracic Cancers. Multidisciplinary Thoracic Cancers Symposium, San Francisco. March 2017.
  • Jacobs C, Jafari ME. How Low is Low? Radiation Dose Assessment of Low Dose Chest Computed Tomography for Lung Cancer Screening. Poster presented at American College of Radiation Oncology (ACRO) Annual Meeting. 2017 March 11; Orlando, FL.
  • Jacobs C, Loudas N, Driscoll C. Toxicity Analysis of Lung Stereotactic Body Radiation Therapy (SBRT) at a Community Hospital. Poster presented at American College of Radiation Oncology (ACRO) Annual Meeting. 2017 March 11; Orlando, FL.
  • Gilmore BF, Sun Z, Adam MA, Spiegel DY, Ezekian B, Turner MC, Nag U, Palta M, Migaly J, Mantyh C. IMRT is Superior to 3D-CRT for the Treatment of Anal Cancer. 12th Annual Academic Surgical Congress. 2017 February 7-9; Las Vegas, NV. Abstract #ACS20170492.
  • Spiegel DY, Hong JC, Lee WR, Salama JK. A nomogram for testosterone recovery following combined androgen deprivation therapy and radiation therapy for prostate cancer (Poster presentation). 2017 Genitourinary Cancers Symposium, Orlando. February 2017.
  • Tandberg DJ, Hong JC, Cui Y, Ackerson BG, Czito BG, Willett CW, Palta M. Interim FDG-PET imaging during neoadjuvant chemoradiotherapy for esophageal cancer: Correlation with pathologic response. Poster presentation, 2017 Gastrointestinal Cancers Symposium, San Francisco, January 2017.
2016
  • Mowery YM, Kent CL, Wisdom AJ, Van Mater D, Castle KD, Luo L, Reinsvold M, Ma Y, Reddy A, Dave S, Kirsch DG. Evaluating the impact of tumor mutational load on response to immune checkpoint inhibition and radiotherapy in primary mouse models of soft tissue sarcoma. Oral presentation. Radiation Research Society (RRS) Annual Meeting. October 16, 2016. Waikoloa Village, HI.
  • Mowery YM, Patel K, Olson AC, Khan MK, Salama JK, Salama AK. Toxicity and Survival for Metastatic Melanoma Patients Treated with Anti-PD1 Therapy and Radiation Treatment. American Society for Radiation Oncology (ASTRO) Annual Meeting. Oral presentation. September 28, 2016. Boston, MA.
  • Mowery YM, Salama JK, Zafar SY, Moore HG, Willett CG, Czito B, Hopkins MB, Palta M. Radiation Oncologists' Practice Patterns and Attitudes Regarding Neoadjuvant Short-Course Radiation Therapy for Rectal Cancer in the United States. ePoster session. American Society for Radiation Oncology (ASTRO) Annual Meeting. September 27, 2016. Boston, MA.
  • Jacobs C, Borgert A, Jafari ME. Early Results of Lung Cancer Screening by Low-Dose Computed Tomography at a Community Hospital. Poster presented at American Society for Radiation Oncology (ASTRO) 58th Annual Meeting. 2016 September 26; Boston, MA.
  • Kent CL, Mowery YM, Wisdom AJ, Van Mater D, Castle KD, Reddy A, Dave SS, Kirsch DG. Immune Checkpoint Inhibition and Radiation Therapy in 2 Primary Mouse Models of Soft Tissue Sarcoma: Impact of Tumor Mutational Load. American Society for Radiation Oncology (ASTRO) Annual Meeting. September 26, 2016. Boston, MA.
  • Kent CL, Mowery YM, Wright AO, Kim GJ, Desjardins A, Peters KB, Vlahovic G, Friedman HS, Cummings TJ, McLendon RE, Friedman AH, Sampson JH, Kirkpatrick JP. Long-Term Outcomes for Patients with Atypical or Malignant Meningiomas Treated with Radiation Therapy: A Single-Institution Retrospective Analysis. American Society for Radiation Oncology (ASTRO) Annual Meeting. September 26, 2016. Boston, MA.
  • Olson AC, Patel K, Mowery YM, Wynne J, Ready N, Kirkpatrick JP, Salama AK, Khan MK. Anti-PD-1 Therapy and Stereotactic Radiation for Melanoma and Non-Small Cell Lung Cancer Patients with Brain Metastases: A 2-Institution Series. American Society for Radiation Oncology (ASTRO) Annual Meeting. September 26, 2016. Boston, MA.
  • Mowery YM, Vergalasova I, Yoo DS, Limon D, Das SK, Hara WY, Brizel DM. 18F-FDG PET/CT Response at 20 Gy Predicts Treatment Outcome for Head and Neck Squamous Cell Carcinoma (HNSCC). American Society for Radiation Oncology (ASTRO) Annual Meeting. September 26, 2016. Boston, MA.
  • Spiegel DY, Marcom PK, Peterson B, Force J, Howie L, Palta M, Blitzblau R, Horton J. Acute toxicity in patients with HER2-positive breast cancer treated with adjuvant radiotherapy and concurrent trastuzumab and pertuzumab. Poster #2023. 58th Annual Meeting of the American Society for Therapeutic Radiology and Oncology. September 26, 2016. Boston, MA.
  • Boyer MJ, Williams CD, Kelley MJ, and Salama JK. Improved Survival with Stereotactic Body Radiation Therapy (SBRT) Compared to Conventional Radiation in Stage I NSCLC: A Veteran’s Affairs Central Cancer Registry (VACCR) Study. Oral Presentation. American Society for Radiation Oncology Annual Meeting, Boston, MA, September 2016.
  • Boyer MJ, Rushing C, Peterson B, Papagikos MA, Kiteley R, and Lee WR. Toxicity and Quality of Life Report of a Phase II Study of Stereotactic Body Radiotherapy (SBRT) for Low and Intermediate Risk Prostate Cancer. Poster Presentation American Society for Radiation Oncology Annual Meeting, Boston, MA, September 2016.
  • Chino F, Peppercorn J, Rushing C, Samsa G, Nicolla J, Altomare I, Zafar SY. “Going for Broke”: Out of Pocket Costs, Financial Distress and Patient-reported Willingness to Pay and Sacrifice in Cancer Care Accepted for Presentation at the American Society for Radiation Oncology Annual Meeting, Boston, MA. September 2016. [Oral Presentation].
  • Hong JC, Eng J, Faught A, Higgins K, Cui Y, Yin FF, Das S, Czito B, Willett C, Palta M. Interim FDG-PET imaging during chemoradiation for squamous anal canal carcinoma (Poster presentation). 58th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, Boston. September 2016.
  • Hong JC, Foote J, Broadwater G, Sosa J, Gaillard S, Havrilesky L, Chino J. Total treatment duration for cervical cancer: Is 55 days still the goal in the era of concurrent chemotherapy? (Oral presentation). 58th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, Boston. September 2016.
  • Hong JC, Gross CP, Shafman T, Hu X, Yu J, Ross R, Finkelstein S, Dosoretz A, Park H, Soulos P, Evans S. Modern Radiotherapy for Left –Sided Breast Cancer: An Analysis of Mean Heart Dose within Diverse Practice Settings (ePoster discussion). 58th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, Boston. September 2016.
  • Martella AP, Hong JC, Foote J, Havrilesky LJ, Gaillard S, Chino JP. Chemotherapy and radiotherapy in stage III endometrial cancer and the impact of time to treatment initiation: A National Cancer Data Base study (Poster presentation). 58th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, Boston. Setpember 2016.
  • Tandberg DJ, Cahill J, Kelsey CR. Biological Predictors of Radiation Esophagitis in Locally-Advanced Lung Cancer: A Secondary Analysis from a Prospective Study. Poster presentation, 58th annual meeting American Society of Radiation Oncology, Boston, September 2016.
  • Loman K, Nawrocki J, Hoang J, Yoo D, Chang Z, Mowery Y, Li X, Peterson B, Brizel D, Craciunescu O. Establishing Relevant ADC-Based Texture Analysis Metrics for Quantifying Early Treatment-Induced Changes in Head and Neck Squamous Cell Carcinoma. American Association of Physicists in Medicine Annual Meeting. August 1, 2016. Washington, DC.
  • Olson AC, Craciunescu O, Meltsner S, Cai J, Cheng JZ, Chino JP. Dosimetry, Feasibility, and Acute Toxicity of Combined Intracavitary Brachytherapy and Free-Hand Interstitial Needle Placement for Locally Advanced Cervix and Uterine Cancer. World Congress of Brachytherapy; 2016 June 27-29; San Francisco, CA. Oral Presentation.
  • Hong JC, Foote J, Havrilesky LJ, Gaillard S, Chino JP. Chemotherapy and radiotherapy in early stage uterine papillary serous and clear cell carcinoma: A National Cancer Data Base study (Poster presentation). 2016 ASCO Annual Meeting, Chicago. June 2016.
  • Schroeder K, Olson AC, Ackerson B, Larrier NL, Masalu N, Chao N, Likonda B. Radiation needs in pediatric oncology in the lake region of Tanzania. Symposium on Global Cancer Research, CUGH Annual Conference. 2016 April; San Francisco, CA. Poster Presentation.
  • Cramer CK, Yoon SW, Reinsvold M, Joo KM, Norris H, Hood RC, Adamson JD, Klein RC, Kirsch DG, Oldham M. Treatment planning and delivery of whole brain irradiation with hippocampal avoidance in rats. 3rd Symposium on Small Animal Precision Image-Guided RadioTherapy, Ghent, 2016 March 21-23.
  • Mowery YM, Vergalasova I, Limon D, Yoo DS, Das SK, Hara WY, Brizel DM. Intra-treatment 18F-FDG-PET/CT as an Imaging Biomarker for Head & Neck Caner. 2016 Radiation Oncology & Imaging Program Annual Retreat. March 14, 2016. Durham, NC.
  • Mowery Y, Craciunescu O, Light K, Chino J. Incorporating a color-coded graphical interface into radiation treatment planning software to improve safety for patients undergoing external beam pelvic radiotherapy for gynecologic malignancies. 11th Annual Duke Health Patient Safety and Quality Conference. March 10, 2016. Durham, NC.
  • Mowery YM, Vergalasova I, Yoo DS, Das SK, Hara WY, Brizel DM. Correlating Clinical Outcomes with Changes in Tumor Volume and 18F-FDG PET Characteristics during Radiotherapy (RT) for Head and Neck Squamous Cell Carcinoma (HNSCC). Poster #227. 2016 Multidisciplinary Head and Neck Cancer Symposium. February 18, 2016. Scottsdale, AZ.
  • Tumati V, Jacobs C, Ying J, Roehrborn CG, Lotan Y, Margulis V, Pistenmaa D, Kim DW, Hannan R. Outcomes in high-risk prostate cancer patients treated with definitive versus adjuvant radiation therapy. Poster presented at American Society of Clinical Oncology Genitourinary Cancer Symposium. 2016 January 9; San Francisco, CA.
2015
  • Qin R, Singh B, Olson AC, Bhavsar N, Wolf S, Salama JK, Kirkpatrick JP, Salama AK. Safety and efficacy of radiation in advanced melanoma patients treated with ipilimumab. Society for Melanoma Research 2015 Congress. 2015 November 18-21, San Francisco, CA. Poster Presentation.
  • Mowery Y, Kim G, Wright A, Desjardins A, Peters K, Vlahovic G, Friedman H, Sampson J, Kirkpatrick J. Outcomes for Patients With Intracranial Meningiomas Treated With Radiation therapy and Bevacizumab: A Single-Institution Retrospective Analysis. Poster #2265. American Society for Radiation Oncology (ASTRO) 2015 Annual Meeting. October 19, 2015. San Antonio, TX.
  • Mowery Y, Vergalasova I, Yoo D, Das S, Brizel D. Correlating Outcomes With Changes in Tumor Volume and 18F-FDG PET Characteristics During Radiation Therapy for Head and Neck Squamous Cell Carcinoma (HNSCC). Poster #2835. American Society for Radiation Oncology (ASTRO) 2015 Annual Meeting. October 19, 2015. San Antonio, TX.
  • Olson AC, Qin R, Singh B, Bhavsar N, Wolf S, Salama JK, Kirkpatrick JP, Salama AK. Radiosurgery for Brain Metastases in Melanoma Patients Receiving Ipilimumab. ASTRO Annual Meeting; 2015 October 18-21; San Antonio, TX. Poster Presentation.
  • Robinson TJ, Zhang M, Kirsch DG. Next Generation Sequencing of Sarcoma Cells with HIF-1a Deletion Reveals Context-Dependent Regulation of HIF-1 Transcriptional Targets Induced by Radiation vs. Hypoxia. ASTRO 2015. October 2015. [electronic poster and short podium presentation].
  • Torok JA, Castle KD, Reinsvold M, Kirsch DG. Modulation of endothelial cell radiation sensitivity and lung tumor response to radiation therapy. Poster and oral presentation at the American Society of Therapeutic Radiation Oncology 2015 Annual Conference. October 2015.
2014
  • Cramer CK. The Role of Radiotherapy in Retroperitoneal Sarcoma. Presentation to the Sarcoma Group at Duke University Hospital. December 16, 2014.
  • Mowery YM, Greenup RA, Houck K, Palta M, Horton JK, Sosa JA, Hwang ES, Blitzblau RC. Low utilization of hypofractionated radiotherapy for the treatment of early-stage breast cancer in the US. San Antonio Breast Cancer Symposium. December 2014. San Antonio, TX.
  • Mowery Y, Wright A, Desjardins A, Peters K, Ranjan T, Vlahovic G, Friedman H, Zomorodi A, Kaylie D, Adogwa O, Nimjee S, Sperduto W, Chagoya G, Fatemi P, McLendon R, Cummings T, Friedman A, Sampson J, Kirkpatrick J. Long-term outcomes for patients with intracranial meningiomas: a single-institution retrospective analysis. Poster MS-19. Society for Neuro-Oncology 2014 Annual Meeting. November 14, 2014. Miami, FL.
  • Boyle J, Dorth, Craciunescu O, Steffey B, Light K, Chino J. Simultaneous Integrated Boost to Pelvic and Paraaortic Nodes from Cervical Cancer Improves the Dosimetric Therapeutic Ratio [abstract]. In: American Society for Radiation Oncology Annual Meeting 2014. September 14-17; San Francisco, CA; Fairfax, VA: ASTRO; 2014.
  • Boyle J, Smoking History Predicts for Increased Risk of Second Primary Lung Cancer: A Comprehensive Analysis, American Society of Radiation Oncology (ASTRO) Annual Meeting Oral Presentation- September 14-17, 2014, San Francisco, CA.
  • Olson AC, Das S, May R, Czito B, Kelsey C, Patel P. Normal Tissue Toxicity Risk Assessment with Interim 18F-FDG PET-CT in Patients with Non-Small Cell Lung Cancer Undergoing Radiotherapy. ASTRO Annual Meeting; 2014 Sept 14-17; San Francisco, CA. Poster Presentation.
  • Mowery Y, Vergalasova I, Pura J, Peterson B, Yoo D, Das S, Brizel D. Changes in Tumor Volumes and 18F-FDG PET characteristics during Radiotherapy for HPV+ and HPV- Head and Neck Squamous Cell Carcinoma (HNSCC). Poster #2886. American Society for Radiation Oncology (ASTRO) 2014 Annual Meeting. September 2014. San Francisco, CA.
  • Robinson TJ, Dewhirst M, Chi JT. Hypoxia induces mRNA 3'UTR truncation in multiple cell types in vitro. ASTRO 2014 [poster presentation]. September 2014.
  • Tandberg DJ, Kelsey CR, Berry MF. Invasive sampling of PET positive aortopulmonary window lymph nodes in patients with right-sided non-small cell lung cancer is not always necessary to guide treatment. Poster presentation, 56th annual meeting American Society of Radiation Oncology, San Francisco, September 2014.
  • Torok JA, Wu Y, Prosnitz LR, Kim G, Beaven AW, Diehl LF, Kelsey CR. Low-dose consolidation radiation therapy for early-stage unfavorable Hodgkin lymphoma. Poster presentation at the American Society of Therapeutic Radiation Oncology 2014 Annual Conference. September 2014.
  • Cramer CK, Palta M, Pura J, Patel P, and Brizel DM. Ipsilateral Tonsil Chemoradiation in the IMRT Era: Effective Local-Regional Control with Reduced Toxicity. Poster presentation for 2014 Multidisciplinary Head and Neck Symposium, Scottsdale, AZ, Feb 20-22, 2014.
2013
  • Boyle JM, Dorth J, Craciunescu O, Steffey B, Light K, Chino J. Initial Safety and Feasibility of Dose Escalation Using a Simultaneous Integrated Boost in Patients with Locally Advanced Gynecologic Malignancies. (poster presentation). 55th Annual ASTRO Meeting. Atlanta, Georgia. September 22-25, 2013.
  • Cramer CK, Chino J. Decreased Radiation Utilization During The Economic Crisis Of 2008-2009. (poster presentation). 55th Annual ASTRO Meeting. Atlanta, Georgia. September 22-25, 2013.
  • Lewis SL, Porceddu S, Hoskin P, Chmura S, Moghanaki D, Lo S, Palma D, Nakamura N, Salama J. An International Survey of Definitive SABR for Extra-cranial Limited Metastases. (poster presentation). 55th Annual ASTRO Meeting. Atlanta, Georgia. September 22-25, 2013.
  • Patel PR, Palta M, Clough R, Yoo D, Brizel DM. Reduced Volume Irradiation for Head and Neck Cancer of Unknown Primary (HNCUP). (poster presentation). 55th Annual ASTRO Meeting. Atlanta, Georgia. September 22-25, 2013.
  • Perez BA, Patel PR, Yoo S, O'Neill L, Livengood KP, Catalano S, Chollet CT, Blitzblau RC. (poster presentation). Evaluating Radiation Dose to the Heart with Left Whole Breast Radiotherapy in Prone, Supine Breath Hold, and Supine Free Breathing Positions. 55th Annual ASTRO Meeting. Atlanta, Georgia. September 22-25, 2013.
  • Robinson TJ, Dewhirst M. Detection of Novel Hypoxia Induced Changes in Alternative mRNA Processing Associated with Clinical Prognosis in Adenocarcinoma of the Lung. (poster presentation). 55th Annual ASTRO Meeting. Atlanta, Georgia. September 22-25, 2013.
  • Torok J, Kelsey C, Salama J. Patterns of Distant Metastases in Surgically Managed Early Stage Non-Small Cell Lung Cancer (poster presentation). 55th Annual ASTRO Meeting. Atlanta, Georgia. September 22-25, 2013.
  • Chino F, Peppercorn J, Tulsky J, Ubel P, Schrag D, Rushing C, Nicolla J, Altomare I, Samsa G, Abernethy A, Zafar SY. The financial burden of cancer care: Do patients know what to expect? J Clin Oncol 31, 2013 (suppl; abstr 6516). Presented at ASCO Annual Meeting, Chicago, IL. June 2013. [Poster Discussion Session]
  • Chino F, Peppercorn J, Tulsky J, Ubel P, Schrag D, Rushing C, Nicolla J, Altomare I, Samsa G, Abernethy A, Zafar SY. The financial burden of cancer care: What are patients’ attitudes toward their costs? Presented at the International Conference on Communication in Healthcare, Montreal, Canada. September 2013. [Oral Presentation].
  • Zafar SY, Abernethy A, Tulsky J, Ubel P, Schrag D, Rushing C, Chino F, Nicolla J, Altomare I, Samsa G, Peppercorn J. Financial distress, communication, and cancer treatment decision making: Does cost matter? J Clin Oncol 31, 2013 (suppl; abstr 6506). Presented at ASCO Annual Meeting, Chicago, IL. June 2013. [Oral Presentation].
  • Boyle J. Body mass index and Dosimetery of Vaginal Brachytherapy. 2013 American Brachytherapy Society (ABS) Annual Meeting. New Orleans, LA. April 18-20, 2013.
  • Boyle J. Body mass index, dose to organs at risk during vaginal brachytherapy, and the role of three-dimensional CT-based treatment planning, American Brachytherapy Society (ABS) Annual Meeting Oral Presentation – April 18-20, 2013, New Orleans, LA.
  • Robinson TJ, Dinan MA, Li Y, Lee WR, Reed SR. Longitudinal trends in costs of palliative radiation for Medicare beneficiaries in the last year of life who died between 2000 and 2007. ASCO 2013 and ASTRO 2013 [poster presentation].
2012
  • Boyle J. The Role of Radiation Therapy in Hodgkin Lymphoma, Resurrection Health Care Oncology Grand Rounds – December 22, 2012, Evanston, IL.
  • Cuneo KC, Vredenburgh J, Desjardins A, Peters K, Sampson J, Allen K, Chang Z, Duffy E, Peterson B, Kirkpatrick JP. Impact of Concurrent and Adjuvant Bevacizumab on the Risk of Radiation Necrosis Following Radiosurgery for Recurrent Glioma, Int J Rad Oncol Biol Phys, Volume 84, Issue 3, Supplement, 1 November 2012, Page S7
  • Czito B, Willett C, Palta M, Kennedy-Newton P, Uronis H. A Phase I/II Study of Capecitabine (Cape), Oxaliplatin (Ox), Panitumumab (Pmab), and External Beam Radiation Therapy (RT) for Patients With Esophagogastric Carcinoma (EC), Int J Rad Oncol Biol Phys, Volume 84, Issue 3, Supplement, 1 November 2012, Page S42
  • Dorth JA, Prosnitz L, Broadwater G, Beaven A, Kelsey C, Radiation Therapy Dose-Response Analysis for Diffuse Large B-cell Lymphoma With a Complete Response to Chemotherapy, Int J Rad Oncol Biol Phys, Volume 84, Issue 3, Supplement, 1 November 2012, Page S615
  • Dorth, JA, Prosnitz LR, Broadwater G, Diehl LF, Beaven AW, Coleman RE, Kelsey CR. Impact of Consolidation Radiation Therapy in Stage III-IV Diffuse Large B-cell Lymphoma With Negative Post-Chemotherapy Radiologic Imaging, Int J Rad Oncol Biol Phys, Volume 84, Issue 3, 1 November 2012, Pages 762-767.
  • Kelsey CR, Higgins K, Peterson B, Marks LB, Tandberg D, Chino J, DeCamp M, Varlotto J. Analysis of Prognostic Factors Affecting Local and Distant Recurrence Following Surgery for Non-small Cell Lung Cancer: A Recursive Partitioning Analysis, Int J Rad Oncol Biol Phys, Volume 84, Issue 3, Supplement, 1 November 2012, Page S569
  • Lewis S, Vredenburgh J, Desjardins A, Peters K, Green S, Hood R, Yang Y, Sampson J, Wang Z, Kirkpatrick JP, Patterns of Failure as a Function of Clinical Target Volumes in Patients With GBM Treated With Radiation Therapy (RT), Temozolomide, and Bevacizumab, Int J Rad Oncol Biol Phys, Volume 84, Issue 3, Supplement, 1 November 2012, Pages S266-S267
  • Oh DS, Chao HH, Balletta LD, Contreras CM, Perou CM, Radiation-induced Gene Signature Predicts Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Patients, Int J Rad Oncol Biol Phys, Volume 84, Issue 3, Supplement, 1 November 2012, Page S25
  • Palta MP, Patel P, Horton J, Blitzblau R. Use of Adjuvant Radiation Therapy in Elderly Patients With Early Stage Breast Cancer: Changes in Practice Patterns After Publication of Cancer and Leukemia Group B (CALGB) 9343, Int J Rad Oncol Biol Phys, Volume 84, Issue 3, Supplement, 1 November 2012, Page S256
  • Patel PR, Lee J, Kundu D, Temple K, May R, Lee WR, Yoo D, Brizel DM. Postoperative Radiation Therapy for Salivary Gland Tumors: Factors Associated With Treatment Failure and Toxicity, Int J Rad Oncol Biol Phys, Volume 84, Issue 3, Supplement, 1 November 2012, Pages S502-S503
  • Perez B, Vajzovic L, Mettu P, Rivera D, Alkaissi A, Steffey B, Stinnett S, Marks LB, Mruthyunjaya P, Kirsch DG, Evaluating the Relationship Between Prescription Dose and Overall Survival Among Patients Treated With I-125 Brachytherapy for Posterior Uveal Melanoma, Int J Rad Oncol Biol Phys, Volume 84, Issue 3, Supplement, 1 November 2012, Page S197
  • Wright A, Chino J, Kelsey C. Non-small Cell Lung Cancer With Chest Wall Invasion Is Associated With High Rates of Positive Margins and Local Failure After Surgery, Int J Rad Oncol Biol Phys, Volume 84, Issue 3, Supplement, 1 November 2012.
2011
  • Kirkpatrick J. P., M. Palta. MDA Randomized Study to Determine the Optimal PTV for Radiosurgery of Brain Metastatases: A Preliminary Toxicity Review. 97th Scientific Assembly and Annual Meeting of Radiological Society of North America. November 27-December 2, 2011. Chicago, Ilinois.
  • Cramer C. Pseudoprogression in Glioblastoma Multiforme [presentation]. Oncology Grand Rounds Conference, NorthShore University HealthSystem, Evanston, IL Nov. 18, 2011.
  • Cabrera A.R. , O. Craciunescu, K.C. Cuneo, Z. Chang, J.P. Kirkpatrick. Evaluating Recurrent Gliomas with Diffusion-weighted MR Imaging Before and After Concurrent Radiosurgery and Bevacizumab. Proceedings of the American Society for Radiation Oncology 53rd Annual Meeting--Miami Beach, Florida. International Journal of Radiation Oncology Biology Physics: 81(2) 2, Supplement, 1 October 2011, Pages S793.October 2-6, 2011.
  • Cuneo K.C., A.R. Cabrera, J. Sampson, K. Allen, E. Duffy, J.J. Vredenburgh, K.B. Peters, Z. Chang, A. Desjardins, J.P. Kirkpatrick. Bevacizumab and Radiosurgery for Recurrent Malignant Glioma: Toxicity Results from a Prospective Pilot Study. International Journal of Radiation Oncology Biology Physics, Volume 81, Issue 2, Supplement, 1 October 2011, Page S185
  • Cuneo K.C., J.K. Mito, B.E. Brigman, J.M. Ferrer, C. Lee, W.C. Eward, J.E. Carter, D.G. Kirsch. Effects of Radiation Therapy on the Detection of Microscopic Residual Cancer in the Surgical Bed using a Protease-activated Fluorescent Probe in a Primary Soft Tissue Sarcoma Model. International Journal of Radiation Oncology Biology Physics, Volume 81, Issue 2, Supplement, 1 October 2011, Pages S729-S730
  • Dorth J.A. , D.M. Brizel Incidence of Asymptomatic Carotid Artery Stenosis in Survivors of Head and Neck Radiation. International Journal of Radiation Oncology Biology Physics, Volume 81, Issue 2, Supplement, 1 October 2011, Page S76.
  • Higgins K.A. , J.P. Chino, D.S. Yoo, C.R. KelseyLymphovascular Invasion in Non-small Cell Lung Cancer: Implications for Staging and Adjuvant Therapy. International Journal of Radiation Oncology Biology Physics, Volume 81, Issue 2, Supplement, 1 October 2011, Page S573.
  • Kelsey C.R. , J. Chino, D. Yoo, K. Higgins. Pathologic N1 Non-small Cell Lung Cancer: Identifying Subsets of Patients at High Risk of Local Failure. International Journal of Radiation Oncology Biology Physics, Volume 81, Issue 2, Supplement, 1 October 2011, Page S165.
  • Kirkpatrick J.P. , S. Green, T. Zagar, Z. Wang. Balancing Tumor Kill and Normal Tissue Toxicity in Radiosurgery: Critical Impact of the Peritumoral Zone. International Journal of Radiation Oncology Biology Physics, Volume 81, Issue 2, Supplement, 1 October 2011, Page S866.
  • Oh D.S. , H. Song, S. Freedland, L. Gerber, P. Patel, S. Lewis, D. Yoo, J. Oleson, J.K. Salama. Statin Use and Prostate Cancer Recurrence in Men Treated with Brachytherapy. International Journal of Radiation Oncology Biology Physics, Volume 81, Issue 2, Supplement, 1 October 2011, Pages S12-S13.
  • Palta M. , R. Clough, D. Yoo, R. Scher, N. Ready, D. Brizel. Twenty Year Experience with Chemoradiotherapy for Locally Advanced Squamous Cell Carcinoma of the Oropharyn. International Journal of Radiation Oncology Biology Physics, Volume 81, Issue 2, Supplement, 1 October 2011, Pages S503-S504
  • Pepek J.M., J.P. Chino, K.A. Higgins, D.S. Yoo, C.R. Kelsey. Does SUVmax of the Primary Tumor Predict Regional Lymph Node Involvement or Local/Regional Recurrence in Resected Non-small Cell Lung Cancer? International Journal of Radiation Oncology Biology Physics, Volume 81, Issue 2, Supplement, 1 October 2011, Pages S581-S582
  • Pepek J.M., K.A. Higgins, J.P. Chino, D.S. Yoo, C.R. Kelsey. Accuracy of PET in Identifying Hilar (N1) Lymph Node Involvement in Non-small Cell Lung Cancer: Implications for the Radiation Oncologist. International Journal of Radiation Oncology Biology Physics, Volume 81, Issue 2, Supplement, 1 October 2011, Page S53
  • Yue J., J. Yu, A.R. Cabrera, X. Sun, S. Zhao, L. Ma. Measuring Tumor Hypoxia with 18F-FETNIM PET in Esophageal Squamous Cell Carcinoma: A Pilot Clinical Study. International Journal of Radiation Oncology Biology Physics, Volume 81, Issue 2, Supplement, 1 October 2011, Page S319
  • Zagar T.M. , M. Palta, S. Catalano, L. O′Neill, S. Yoo, P. Leonard, J. HortonDosimetric Comparison Of Radiotherapy For Left Sided Breast Cancer: Breath-hold versus Free Breathing. International Journal of Radiation Oncology Biology Physics, Volume 81, Issue 2, Supplement, 1 October 2011, Pages S780-S781.
  • Cuneo KC, Cabrera A, Sampson JH, Reardon DA, Allen KJ, Chang Z, Herndon JE, Kirkpatrick JP. Prospective Study of Radiosurgery and Bevacizumab for Recurrent Malignant Glioma. J Clin Oncol 29:2011(suppl; abstr 2082). ASCO Annual Meeting 2011. June 2011.
  • Robinson TJ, Forte E, Salinas-Mondrigan R, Puri S, Marengo M, Garcia-Blanco MA and Luftig MA. SplicerEX: a tool for the automated detection and classification of mRNA changes from conventional and splice-sensitive microarray expression data. Era of Hope - Dpartment of Defense (DOD) Breast Cancer Research Program (BCRP), 2011, [poster presentation].